In contrast, we recently determined that elevated expression of PD-L2 protein in cancer cells of one-third of ER+ BC, as identified by quantitative fluorescence IHC, was an independent marker of unfavorable prognosis, as validated in independent cohorts from two different institutions based on analyses of 954 patients [5]. This evidence concerns the gene ESR1 and breast cancer.